Retrolaminar Block Versus Erector Spinae Plane Block as Opioid-Free Anesthesia for Enhanced Recovery After Posterior Lumbar Discectomy
Launched by TANTA UNIVERSITY · Dec 5, 2024
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring two different methods of providing anesthesia—called the retrolaminar block and the erector spinae plane block—without using opioids (strong pain medications) for patients undergoing a specific back surgery known as posterior lumbar discectomy. The goal is to see which method helps patients recover better after their surgery while avoiding the potential side effects of opioids.
To participate in this study, you need to be between 18 and 65 years old and in good health (specifically classified as having a physical status of I or II by the American Society of Anesthesiology). You should be scheduled for this type of back surgery and not have certain health conditions, such as being overweight (BMI over 35) or having severe heart or kidney problems. If you join the trial, you'll receive one of the two types of anesthesia during your surgery, and the researchers will monitor how well you recover afterward. This study is currently looking for new participants, and your involvement could help improve pain management techniques for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age from 18 to 65 years.
- • Both sexes.
- • American Society of Anesthesiology (ASA) physical status I-II.
- • Undergoing elective posterior lumbar discectomy under general anesthesia.
- Exclusion Criteria:
- • Body mass index (BMI) \>35 kg/m2.
- • Patients with disturbed mental status.
- • Allergies to the drugs used in the study.
- • Local infection at the puncture site.
- • Cardiac insufficiency.
- • Renal insufficiency.
- • Coagulopathy.
- • Chronic opioid use.
About Tanta University
Tanta University is a prestigious academic institution located in Egypt, dedicated to advancing medical research and education. As a clinical trial sponsor, Tanta University leverages its extensive resources and expertise to conduct innovative research initiatives aimed at improving health outcomes. The university collaborates with a network of healthcare professionals, researchers, and institutions to facilitate rigorous clinical trials across various medical disciplines. Committed to ethical standards and scientific integrity, Tanta University strives to contribute to the global body of knowledge while fostering the next generation of medical professionals.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tanta, El Gharbia, Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported